Overall, these results strongly support that Td vaccine can prime T cells to precisely recognize SARS-CoV-2-specific CD8+ T cell epitopes that were anticipated as cross-reactive with tetanus-diphtheria vaccines. This evidence concerns the gene CD8A and tetanus.